Hiraku Suga

1.9k total citations
67 papers, 1.3k citations indexed

About

Hiraku Suga is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Hiraku Suga has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Dermatology, 29 papers in Immunology and 22 papers in Epidemiology. Recurrent topics in Hiraku Suga's work include Cutaneous lymphoproliferative disorders research (41 papers), Dermatology and Skin Diseases (13 papers) and Nail Diseases and Treatments (12 papers). Hiraku Suga is often cited by papers focused on Cutaneous lymphoproliferative disorders research (41 papers), Dermatology and Skin Diseases (13 papers) and Nail Diseases and Treatments (12 papers). Hiraku Suga collaborates with scholars based in Japan, United States and Brazil. Hiraku Suga's co-authors include Shinichi Sato, Makoto Sugaya, Tomomitsu Miyagaki, Yoshihide Asano, Takafumi Kadono, Hanako Ohmatsu, Tomonori Oka, Hideki Fujita, Makiko Kawaguchi and Yayoi Tada and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Hiraku Suga

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiraku Suga Japan	21	675	620	273	272	216	67	1.3k
Yayoi Tada Japan	23	379 0.6×	728 1.2×	458 1.7×	223 0.8×	289 1.3×	53	1.4k
Laura Y. McGirt United States	16	720 1.1×	298 0.5×	264 1.0×	126 0.5×	208 1.0×	25	1.3k
M. Bhushan United Kingdom	15	438 0.6×	630 1.0×	192 0.7×	136 0.5×	179 0.8×	29	1.1k
P C van de Kerkhof Netherlands	16	530 0.8×	637 1.0×	103 0.4×	102 0.4×	174 0.8×	37	1.1k
Nathalie Pedretti France	14	503 0.7×	719 1.2×	74 0.3×	230 0.8×	298 1.4×	18	1.2k
Andreas Kerstan Germany	20	398 0.6×	550 0.9×	146 0.5×	167 0.6×	406 1.9×	59	1.3k
Giselle Singer United States	18	759 1.1×	297 0.5×	159 0.6×	102 0.4×	106 0.5×	30	1.1k
Sven Quist Germany	21	503 0.7×	153 0.2×	76 0.3×	171 0.6×	373 1.7×	39	1.1k
Xiao‐Yong Man China	20	336 0.5×	398 0.6×	59 0.2×	221 0.8×	335 1.6×	80	1.1k
Katherine C. Pierson United States	13	917 1.4×	1.7k 2.8×	129 0.5×	451 1.7×	406 1.9×	14	2.2k

Countries citing papers authored by Hiraku Suga

Since Specialization

Citations

This map shows the geographic impact of Hiraku Suga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiraku Suga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiraku Suga more than expected).

Fields of papers citing papers by Hiraku Suga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiraku Suga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiraku Suga. The network helps show where Hiraku Suga may publish in the future.

Co-authorship network of co-authors of Hiraku Suga

This figure shows the co-authorship network connecting the top 25 collaborators of Hiraku Suga. A scholar is included among the top collaborators of Hiraku Suga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiraku Suga. Hiraku Suga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hirai, Yoji, Shiho Yoshida, Toshiharu Mitsuhashi, et al.. (2024). Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30‐positive cutaneous T‐cell lymphoma. The Journal of Dermatology. 51(8). 1037–1049. 1 indexed citations

Miyagaki, Tomomitsu, Hiroaki Kamijo, Naomi Shishido, et al.. (2023). Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan. British Journal of Dermatology. 189(5). 612–620. 2 indexed citations

Suga, Hiraku, et al.. (2023). Increased Serum Levels of Tumor Necrosis Factor-like Ligand 1A in Atopic Dermatitis. International Journal of Molecular Sciences. 24(3). 1813–1813. 2 indexed citations

Morimura, Sohshi, Makoto Sugaya, Tomonori Oka, et al.. (2021). Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis. International Journal of Molecular Sciences. 22(4). 2025–2025. 10 indexed citations

Shishido, Naomi, Makoto Sugaya, Hiraku Suga, et al.. (2021). Mycosis fungoides and Sézary syndrome tumor cells express epidermal fatty acid‐binding protein, whose expression decreases with loss of epidermotropism. The Journal of Dermatology. 48(5). 685–689. 6 indexed citations

Kimura, Takayuki, Tomomitsu Miyagaki, Hiraku Suga, et al.. (2021). Lymphatic Dysfunction Exacerbates Cutaneous Tumorigenesis and Psoriasis-Like Skin Inflammation through Accumulation of Inflammatory Cytokines. Journal of Investigative Dermatology. 142(6). 1692–1702.e3. 1 indexed citations

Kamijo, Hiroaki, Tomomitsu Miyagaki, Tomonori Oka, et al.. (2020). Primary cutaneous γδ T‐cell lymphoma with unusual immunophenotype: A case report and review of published work. The Journal of Dermatology. 47(3). 300–305. 3 indexed citations

Kamijo, Hiroaki, Tomomitsu Miyagaki, Yoshio Hayashi, et al.. (2019). Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis. Journal of Investigative Dermatology. 140(3). 636–644.e2. 42 indexed citations

Kamijo, Hiroaki, Rina Nakajima, Tomonori Oka, et al.. (2019). YKL-40 Promotes Proliferation of Cutaneous T-Cell Lymphoma Tumor Cells through Extracellular Signal–Regulated Kinase Pathways. Journal of Investigative Dermatology. 140(4). 860–868.e3. 10 indexed citations

10.

Suga, Hiraku, Tomonori Oka, Makoto Sugaya, et al.. (2019). Keratinocyte Proline-Rich Protein Deficiency in Atopic Dermatitis Leads to Barrier Disruption. Journal of Investigative Dermatology. 139(9). 1867–1875.e7. 16 indexed citations

11.

Kamijo, Hiroaki, Tomomitsu Miyagaki, Naomi Shishido, et al.. (2019). Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47. Leukemia. 34(3). 845–856. 52 indexed citations

12.

Nakajima, Rina, Tomomitsu Miyagaki, Hiroaki Kamijo, et al.. (2019). Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma. Journal of Dermatological Science. 96(3). 134–142. 19 indexed citations

13.

Kamijo, Hiroaki, Tomomitsu Miyagaki, Naomi Shishido, et al.. (2018). Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma. Blood. 132(18). 1922–1935. 30 indexed citations

14.

Miyagaki, Tomomitsu, Rina Nakajima, Hiroaki Kamijo, et al.. (2018). Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides. European Journal of Dermatology. 28(3). 314–319. 8 indexed citations

15.

Miyagaki, Tomomitsu, Hiroaki Kamijo, Tomonori Oka, et al.. (2017). Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome. The Journal of Dermatology. 45(1). 95–99. 12 indexed citations

16.

Miyagaki, Tomomitsu, Rina Nakajima, Tomonori Oka, et al.. (2017). Increased endocan expression in lesional skin and decreased endocan expression in sera in atopic dermatitis. The Journal of Dermatology. 44(12). 1392–1395. 4 indexed citations

17.

Kawaguchi, Makiko, Makoto Sugaya, Hiraku Suga, et al.. (2014). Serum Levels of Angiopoietin-2, but not Angiopoietin-1, are Elevated in Patients with Erythrodermic Cutaneous T-cell Lymphoma. Acta Dermato Venereologica. 94(1). 9–13. 17 indexed citations

18.

Miyagaki, Tomomitsu, Makoto Sugaya, Hiraku Suga, et al.. (2012). Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma. Archives of Dermatological Research. 304(5). 401–406. 14 indexed citations

19.

Sugaya, Makoto, Yoshihiro Kuwano, Hiraku Suga, et al.. (2011). Lymphatic Dysfunction Impairs Antigen-Specific Immunization, but Augments Tissue Swelling Following Contact with Allergens. Journal of Investigative Dermatology. 132(3). 667–676. 20 indexed citations

20.

Miyagaki, Tomomitsu, Makoto Sugaya, Hiraku Suga, et al.. (2011). Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T‐cell lymphoma and psoriasis in combination with serum thymus and activation‐regulated chemokine levels. Journal of the European Academy of Dermatology and Venereology. 27(1). 19–24. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact